Elisabeth M. Paietta, Ph.D.

Medicine

Phone718-920-9520
Emailepaietta@montefiore.org
Websitehttp://www.einstein.yu.edu/faculty/7920/elisabeth-paietta/

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Elisabeth M. Paietta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Finished

ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER
Levine, R., Melnick, A. M., Melnick, A. M., Paietta, E. M., Rose, S. A., Rose, S. A., Rose, S. A. & Paietta, E. M.
National Cancer Institute
4/14/14 → 8/31/19
Project: Research project

21965 Citations
75 h-Index
264 Article
16 Letter
9 Review article
6 Comment/debate
More

Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia
Gocho, Y., Liu, J., Hu, J., Yang, W., Dharia, N. V., Zhang, J., Shi, H., Du, G., John, A., Lin, T. N., Hunt, J., Huang, X., Ju, B., Rowland, L., Shi, L., Maxwell, D., Smart, B., Crews, K. R., Yang, W., Hagiwara, K. & 27 others, Zhang, Y., Roberts, K., Wang, H., Jabbour, E., Stock, W., Eisfelder, B., Paietta, E., Newman, S., Roti, G., Litzow, M., Easton, J., Zhang, J., Peng, J., Chi, H., Pounds, S., Relling, M. V., Inaba, H., Zhu, X., Kornblau, S., Pui, C. H., Konopleva, M., Teachey, D., Mullighan, C. G., Stegmaier, K., Evans, W. E., Yu, J. & Yang, J. J., Mar 2021, In: Nature Cancer. 2, 3, p. 284-299 16 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial
Ganzel, C., Wang, X. V., Rowe, J. M., Richards, S. M., Buck, G., Marks, D. I., Litzow, M. R., Paietta, E. M., Foroni, L., Luger, S. M., Willman, C. L., Mullighan, C. G., Roberts, K. G., Wiernik, P. H., Douer, D., Lazarus, H. M., Tallman, M. S. & Goldstone, A. H., Oct 1 2020, In: British Journal of Haematology. 191, 1, p. 37-43 7 p.
Research output: Contribution to journal › Article › peer-review
In Ph+BCR-ABL1^P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent
Baccarani, M., Iacobucci, I., Chiaretti, S., Foà’, R., Balasubramanian, P., Paietta, E., Foroni, L., Jeromin, S., Izzo, B., Spinelli, O., Varma, N., Menif, S., Terragna, C., Seth, T., Bidet, A., Coriu, D., Lunghi, F., Mayer, J., Scappini, B., Langabeer, S. & 24 others, Maier, J., Burt, E., Candoni, A., Albano, F., Luppi, M., Zupan, I., Lion, T., Zadro, R., di Raimondo, F., Poopak, B., Rege-Cambrin, G., Annunziata, M., Ayala, A., Salinas-Viedma, V., Ines Prado, A., Milner, B., Galimberti, S., Janssen, J., Polli, V., Comba, L., Borsellino, B., Annibali, O., Crugnola, M. & Passamonti, F., Mar 1 2020, In: Leukemia. 34, 3, p. 929-931 3 p.
Research output: Contribution to journal › Letter › peer-review

1 Scopus citations
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia
Oshima, K., Zhao, J., Pérez-Durán, P., Brown, J. A., Patiño-Galindo, J. A., Chu, T., Quinn, A., Gunning, T., Belver, L., Ambesi-Impiombato, A., Tosello, V., Wang, Z., Sulis, M. L., Kato, M., Koh, K., Paganin, M., Basso, G., Balbin, M., Nicolas, C., Gastier-Foster, J. M. & 10 others, Devidas, M., Loh, M. L., Paietta, E., Tallman, M. S., Rowe, J. M., Litzow, M., Minden, M. D., Meijerink, J., Rabadan, R. & Ferrando, A., Nov 2020, In: Nature Cancer. 1, 11, p. 1113-1127 15 p.
Research output: Contribution to journal › Article › peer-review
Targeted detection and quantitation of histone modifications from 1,000 cells
Abshiru, N. A., Sikora, J. W., Camarillo, J. M., Morris, J. A., Compton, P. D., Lee, T., Neelamraju, Y., Haddox, S., Sheridan, C., Carroll, M., Cripe, L. D., Tallman, M. S., Paietta, E. M., Melnick, A. M., Thomas, P. M., Garrett-Bakelman, F. E. & Kelleher, N. L., Oct 2020, In: PloS one. 15, 10 October, e0240829.
Research output: Contribution to journal › Article › peer-review

Open Access

ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER

Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia

At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial

In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent

Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia

Targeted detection and quantitation of histone modifications from 1,000 cells

In Ph+BCR-ABL1^P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent